financetom
Business
financetom
/
Business
/
Tik Tok Divestiture Neutral for Oracle But a Ban Would Slow Cloud Infrastructure Growth, UBS Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Tik Tok Divestiture Neutral for Oracle But a Ban Would Slow Cloud Infrastructure Growth, UBS Says
Apr 22, 2024 9:11 AM

11:49 AM EDT, 04/22/2024 (MT Newswires) -- A TikTok divestiture would be roughly neutral for Oracle (ORCL), while a ban would be a six-to-nine month growth headwind for Oracle Cloud Infrastructure beginning as early as the February 2025 quarter, UBS said in a note Monday.

In a divestiture, the buyer of Tik Tok's operations would probably continue the current OCI contract until the termination date, the analysts said.

But in ban or shut-down scenario, Oracle would lose what is likely its largest OCI customer, UBS said, adding that this could be mitigated by a repurposing of the unused capacity, UBS said.

The recent decline in Oracle's stock suggests the market has already adjusted the price to reflect the uncertainties related to TikTok, according to the note.

The bulk of TikTok's cloud usage peaked in 2022 and it has not been a significant driver of recent revenue growth for Oracle Cloud Infrastructure, the firm added.

UBS reiterated its buy rating on Oracle's stock and kept the price target at $150.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Myriad Genetics Disputes Inclusion of GeneSight in UnitedHealthcare's Coverage Restriction
Myriad Genetics Disputes Inclusion of GeneSight in UnitedHealthcare's Coverage Restriction
Nov 4, 2024
10:56 AM EST, 11/04/2024 (MT Newswires) -- Myriad Genetics ( MYGN ) said Monday that it strongly disagrees with UnitedHealthcare's decision to restrict coverage access to multi-gene panel pharmacogenetic tests, including Myriad's GeneSight test, under the commercial and individual exchange benefit plans. The updated policy, which takes effect on Jan. 1, is based on the rationale that there is insufficient...
LoanDepot, Smith Douglas Homes Form Joint Venture to Support Financing for New Home Buyers
LoanDepot, Smith Douglas Homes Form Joint Venture to Support Financing for New Home Buyers
Nov 4, 2024
10:56 AM EST, 11/04/2024 (MT Newswires) -- LoanDepot ( LDI ) and Smith Douglas Homes ( SDHC ) said Monday they established a joint venture called Ridgeland Mortgage to support financing for new home buyers. The joint venture will operate in Atlanta, Georgia; Houston, Texas; Birmingham and Huntsville, Alabama; Charlotte and Raleigh, North Carolina; and Chattanooga and Nashville, Tennessee, the...
Market Chatter: AstraZeneca Says Obesity Pill Well-Tolerated by Patients
Market Chatter: AstraZeneca Says Obesity Pill Well-Tolerated by Patients
Nov 4, 2024
10:53 AM EST, 11/04/2024 (MT Newswires) -- AstraZeneca ( AZN ) said its experimental obesity pill was well-tolerated by patients with type-2 diabetes, Bloomberg reported Monday, citing comments made by a company executive at the ObesityWeek conference in San Antonio, Texas. Over four weeks in an early study, the oral GLP-1 resulted in patients losing an average of 5.8% of...
Gladstone Capital Sells Stake in Antenna Research Associates
Gladstone Capital Sells Stake in Antenna Research Associates
Nov 4, 2024
10:54 AM EST, 11/04/2024 (MT Newswires) -- Gladstone Capital ( GLAD ) said Monday it sold its equity interest and prepaid its debt investment in Antenna Research Associates. The company said it made a significant gain on its equity investment in ARA, six years after acquiring it in partnership with Antenna management and institutional co-investors. Other details weren't disclosed. Price:...
Copyright 2023-2026 - www.financetom.com All Rights Reserved